Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
SAUD3.SA
Strong BuyBradsaúde S.A. · Healthcare · Brazil · $7.9B · Avg Vol: $11M/d
COMPANY DESCRIPTION
Bradsaúde S.A. provides private dental care plans in Brazil. The company operates through Corporate, Small and Medium-Sized Enterprise (SME), Individual, and Other segments. The company manages and sells dental care plans to corporations and/or individuals.
FINANCIAL SUMMARY (BRL)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.9B | 2.1B | 2.3B | 2.4B | 9.3% | 10.8B | 47.7B | 55.5B | 379.0% |
| EPS (BRL) | 0.13 | 0.17 | 0.18 | 0.20 | 16.8% | 1.14 | 0.27 | 0.30 | 21.8% |
| Shares | 2.9B | 2.9B | 2.9B | 2.9B | 0.0% | 2.9B | — | — | — |
| Debt | 20.4M | 30.9M | 25.8M | 20.8M | 0.7% | 207.1M | — | — | — |
| Equity | 1.1B | 1.4B | 1.2B | 1.3B | 4.4% | — | — | — | — |
| Op CF | 694.6M | 414.6M | 541.7M | 590.1M | -5.3% | 653.7M | — | — | — |
| Inv CF | -355.4M | -233.1M | 79.3M | 99.1M | — | — | — | — | — |
| Fin CF | -339.8M | -182.9M | -618.9M | -685.8M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of SAUD3.SA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| SAUD3.SA | Bradsaúde S.A.(you) | $7.9B | 97 | Strong Buy |
| QUAL3.SA | Qualicorp Consultoria e Corretora de Seguros S.A. | $93M | 88 | Strong Buy |
| HYPE3.SA | Hypera S.A. | $3.0B | 96 | Strong Buy |
| RDOR3.SA | Rede D'Or São Luiz S.A. | $15.3B | 83 | Strong Buy |
| FLRY3.SA | Fleury S.A. | $2.0B | 99 | Strong Buy |
| RADL3.SA | Raia Drogasil S.A. | $6.7B | 60 | Hold |
| MATD3.SA | Hospital Mater Dei S.A. | $328M | 96 | Strong Buy |
| PNVL3.SA | Dimed S.A. Distribuidora de Medicamentos | $353M | 93 | Strong Buy |
| OFSA3.SA | Ouro Fino Saúde Animal Participações S.A. | $261M | 98 | Strong Buy |
| BLAU3.SA | Blau Farmacêutica S.A. | $415M | 84 | Strong Buy |
Peer medians: ROE 10.6% · P/E 13.3x · Gross margin 31.0%